| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |